In this episode of Cannabiz: The Business of Cannabis, the team explore the TGA’s potency audit, which found five out of 22 medical cannabis products tested failed to comply with required standards. The companies concerned have challenged the TGA’s findings. We ask editor-at-large Rhys Cohen: did the TGA jump the gun on potency tests?
Plus, journalist Rachel Williamson joins us to break down her special report, written exclusively for Cannabiz, which considers what Brexit means for Australian cannabis exporters. And finally, co-founders Martin Lane and Kim McKay discuss what they’ve learned in the last 11 weeks following the launch of Cannabiz.